|
|
||||||||
From the Departments of Neurology (Drs. Burdette, Sakurai, Henry, Pennell, Frey, Sackellares, and Albin) and Internal Medicine (Dr. Frey) and the Section of Neurosurgery (Dr. Ross), University of Michigan, Ann Arbor, MI; the Department of Clinical Neuroscience (Dr. Burdette), USAF Medical Center, Wright-Patterson AFB, Dayton, OH; and the Neurology Service (Dr. Sackellares), VA Medical Center, Gainesville, FL.
Article abstract—PET-demonstrated decreases in [11C]flumazenil binding occur in anterior mesial temporal structures on the side of epileptogenesis in unilateral mesial temporal lobe epilepsy. We performed quantitative autoradiog-raphy on anterior mesial and lateral temporal specimens from 11 subjects with unilateral mesial temporal lobe epilepsy and six neurologically normal controls to identify the predominant in vitro correlates of the decreased [11C]flumazenil binding. In anterior mesial temporal regions exhibiting the greatest neuronal cell loss, decreases in agonist and antagonist binding to type 1 and 2 (central) benzodiazepine binding sites were highly correlated with neuronal cell counts. Cell loss and decreased binding were particularly prominent in the lateral portion of hippocampal region CA1, adjacent to CA2. Lateral temporal central benzodiazepine binding was diffusely increased, achieving statistical significance in cortical laminae V and VI. These findings suggest that the predominant source of PET-demonstrated decreases in [11C]flumazenil binding in mesial temporal epilepsy is hippocampal sclerosis, rather than down-regulation of central benzodiazepine binding sites on surviving hippocampal neurons.
This article has been cited by other articles:
![]() |
C. Giffard, B. Landeau, N. Kerrouche, A. R. Young, L. Barre, and J.-C. Baron Decreased Chronic-Stage Cortical 11C-Flumazenil Binding After Focal Ischemia-Reperfusion in Baboons: A Marker of Selective Neuronal Loss? Stroke, March 1, 2008; 39(3): 991 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Laschet, I. Kurcewicz, F. Minier, S. Trottier, J. Khallou-Laschet, J. Louvel, S. Gigout, B. Turak, A. Biraben, J.-M. Scarabin, et al. Dysfunction of GABAA receptor glycolysis-dependent modulation in human partial epilepsy PNAS, February 27, 2007; 104(9): 3472 - 3477. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Loup, F. Picard, V. M. Andre, P. Kehrli, Y. Yonekawa, H.-G. Wieser, and J.-M. Fritschy Altered expression of {alpha}3-containing GABAA receptors in the neocortex of patients with focal epilepsy Brain, December 1, 2006; 129(12): 3277 - 3289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bouvard, N. Costes, F. Bonnefoi, F. Lavenne, F. Mauguiere, J. Delforge, and P. Ryvlin Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study Brain, June 1, 2005; 128(6): 1330 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hammers, M. J. Koepp, R. Hurlemann, M. Thom, M. P. Richardson, D. J. Brooks, and J. S. Duncan Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI Brain, October 1, 2002; 125(10): 2257 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, T. J. Desmond, R. L. Albin, and K. A. Frey Cholinergic vesicular transporters in progressive supranuclear palsy Neurology, April 9, 2002; 58(7): 1013 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hammers, M.J. Koepp, C. Labbe, D.J. Brooks, M. Thom, V.J. Cunningham, and J.S. Duncan Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy Neurology, April 10, 2001; 56(7): 897 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Loup, H.-G. Wieser, Y. Yonekawa, A. Aguzzi, and J.-M. Fritschy Selective Alterations in GABAA Receptor Subtypes in Human Temporal Lobe Epilepsy J. Neurosci., July 15, 2000; 20(14): 5401 - 5419. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lamusuo, A. Pitkanen, L. Jutila, A. Ylinen, K. Partanen, R. Kalviainen, H.-M. Ruottinen, V. Oikonen, K. Nagren, P. Lehikoinen, et al. [11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology Neurology, June 27, 2000; 54(12): 2252 - 2260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.L. Malizia and M.P. Richardson Benzodiazepine receptors and positron emission tomography: ten years of experience. A new beginning? J Psychopharmacol, January 1, 1995; 9(4): 355 - 368. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |